PMOP

常見例句

• In this experiment the effects of Gukang,a compound of herbal medicine,on bone mineral content(BMC) and bone mineral density (BMD) of ovariectomized PMOP rats were observed.
  本實驗旨在觀察骨康口服液對通過切除卵巢誘發(fā)的絕經后骨質疏松癥大鼠模型骨礦含量(BMC)和骨密度(BMD)的影響。
• The paper investigated the relationship between renal deficiency,blood stasis,and PMOP mainly expounded the relationship between types of blood stasis and the process filled PMOP.
  文章探討了腎虛血瘀與絕經后骨質疏松癥的關系,著重闡述了血瘀癥型與絕經后骨質疏松癥發(fā)病過程的關系。
• Objection:To study the relationship of Bone mineral density(BMD)on Postmenopausal Osteoporosis(PMOP)patients Kidney deficiency syndrome and Blood stasis syndrome.
  目的:探討絕經后骨質疏松癥腎虛證與血瘀證之間的關系及內在機制,以提供臨床客觀依據,并指導臨床治療。
• The position of pathological change of PMOP are waist, back, limbs and joints, the viscera of pathological change are kidney, liver and spleen. Pathology is weak essentially and solid phenomenally.
  絕經后骨質疏松癥在中醫(yī)是一種病變部位在腰背四肢及關節(jié),病及腎肝脾,病性屬本虛標實,以腎肝脾虧、氣血不足為本,以風寒濕痹阻、瘀血阻絡為標所致骨髓失養(yǎng)的骨骼疾病。
• Because the human aging-trend increases, the incidence of this disease will increase further, so the PMOP will become the one of main diseases after the menopause threating the elderly"s healthy.
  由于人類老齡化趨勢增加,該病的發(fā)病人數(shù)將會逐年增加,因此,PMOP已成為威脅中老年婦女健康的主要疾病之一。
• Changes and Implications NO and ET in PMOP Patient's Serum
  絕經后骨質疏松癥患者血清NO、ET改變及意義
返回 PMOP